Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

QuidelOrtho (0A55) Share Price & Analysis

1 Followers

0A55 Stock Chart & Stats

$13.56$0.00(0.00%)
At close: 4:30 PM GMT
$25$50$75Dec 2Jun 5Nov 29May 30Dec 2Jan 31Jun 22
Day’s Range
$13.56 - $13.56
52-Week Range
$13.56 - $43.50
Previous Close
$13.56
Volume
N/A
Average Volume (3M)
0
Market Cap
$817.18M
Enterprise Value
$3.70B
Total Cash (Recent Filing)
$166.40M
Total Debt (Recent Filing)
$3.08B
Price to Earnings (P/E)
―
Beta
-0.13
Next Earnings
Feb 17, 2027 (Est.)
EPS Estimate
0.26
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Core Diagnostics Growth

Growth across labs and immunohematology outside China indicates that the company retains customer relationships and platform relevance in core businesses. These areas represent most revenue excluding China, so continued low- to mid-single-digit expansion can provide a durable foundation while weaker markets recover.

Cost Transformation Potential

A defined program with more than $80 million of expected annual savings could materially improve operating leverage and earnings durability. Because the savings are described as incremental to prior actions, successful execution may strengthen cash generation and help fund deleveraging over the next several quarters.

Product And Platform Innovation

Investment in VITROS 450 and NULEXA supports expansion of the company’s diagnostic platform and installed base beyond current products. NULEXA’s planned menu expansion and workflow benefits could increase utilization and recurring consumables demand if commercial adoption develops as expected.

Bears Say

Persistent Profitability Pressure

Multi-period revenue declines combined with continuing net and operating losses show that the business has not yet restored consistent profitability. Even with improved gross and EBITDA margins, weak bottom-line performance limits internally generated capital and leaves results sensitive to further volume or mix pressure.

Weak Cash Generation And Leverage

Near-breakeven operating cash flow and negative free cash flow reduce the company’s ability to self-fund investment, repay debt, or absorb operating setbacks. Combined with meaningful debt and shrinking equity, the current cash profile increases financial risk until profitability and cash conversion improve.

China Pricing And Destocking Risk

China’s pricing-guideline implementation creates a structural headwind through lower reimbursement rates, distributor destocking, and greater competition. The expected revenue mix decline from about 8% in 2026 to 4%-5% in 2027 may weigh on growth and pricing while regional implementation remains uncertain.

QuidelOrtho News

0A55 FAQ

What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest share price was $13.56 and its highest was $43.50 in the past 12 months.
What is QuidelOrtho’s market cap?
QuidelOrtho’s market cap is $817.18M.
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s next earnings report is estimated for Feb 17, 2027 (not yet confirmed), which is in 96 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on Nov 03, 2026. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.202 by $0.108.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Overvalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is 0.26.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 68,612,590 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of $0.31 in its last earnings report, beating expectations of $0.202. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of QuidelOrtho?
Hedge funds hold QuidelOrtho shares: the largest hedge-fund position in QuidelOrtho is 2,073,638,607 shares, and hedge funds decreased their holdings by 439.8K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology